“…Dioxonaphthalimidazopyridine derivatives such as naphth- [2',3':4,5]imidazo [1,2-a]pyridine-6,11-dione and 9-methylnaphth [1',2':4,5]imidazo [1,2-a]pyridine-5,6-dione are interesting chemical entities both as a chromophoric 1 and a pharmacological agent for treating diseases related to venous insufficiency and/or inflammatory edema. 2 Most of the early methods developed for their synthesis are reactions of 2chloro-3-hydroxy-, 2-chloro-3-ethoxy-and 2-chloro-3-acetoxy-1,4-naphthoquinones with 2-aminopyridines, 3 thermolysis of 3-azido-2-chloro-1,4-naphthoquinone in excess of pyridine 1 and condensation reaction of 2,3-dichloro-1,4naphthoquinones with 2-aminopyridine using phase transfer catalyst. 4 Recently, Pérez-Pérez and co-workers reported 5 that the reactions of 6-amino-1-benzyluracil 1 with N-bromosuccinimide (NBS) in pyridine at 80 ºC afforded 6-amino-1benzyl-5-bromouracil 2 and 1-benzyl-1H,3H-pyrido[2,1f]purine-2,4-dione 4 via intermediate dibromo compound 3 (Scheme 1).…”